Skanska AB

Swedenskanska.com

Its role EPC

projects tracked
2
active
2
countries
2
news articles
6

Skanska AB is a Swedish multinational construction and project development company, founded in 1887 and headquartered in Stockholm. The group delivers civil infrastructure and building projects and develops residential and commercial properties across the Nordics, other parts of Europe, and the United States.

Read more

For the chemicals and materials value chain, Skanska is a significant purchaser and specifier of cement, concrete, asphalt, bitumen, aggregates, steel, and building chemicals such as admixtures, sealants, and coatings. The company collaborates with suppliers to reduce lifecycle emissions, expand the use of lower‑carbon concrete and asphalt, and advance circular practices in construction materials. Through its scale and procurement standards, Skanska influences the qualification and adoption of new materials technologies across major infrastructure and building programs.

Projects Skanska is involved in

chemXplore tracks 2 projects involving Skanska, of which 2 are active.

  1. none Announced / Concept
  2. none FEED / Pre-FID
  3. none FID / Sanctioned
  4. 1 project Under Construction
  5. 1 project Commissioning & Start-up

2 more active projects are in the record. See all 2 in chemXplore →

What its projects make

Skanska in chemical industry news

22 October 2026
Roche: Group sales +6% (CER) YTD; Q3 +7% (CER) and +8% in CHF

Group sales +6% (CER) in first nine months; Q3 +7% (CER)/+8% CHF. Pharmaceuticals drove growth, diagnostics up despite China pricing reforms. 2026 outlook confirmed.

15 October 2026
Equinor completes Troll electrification but omits second Troll C export compressor

Partial electrification cuts ~330,000 tonnes CO₂/yr; TWEL will finish after commissioning the first electric export compressor on Troll C and omit the second to avoid up to 21 months outage, freeing ~2.3 bcm gas in 2027–28.

28 September 2026
Genentech breaks ground on $750M Hillsboro device fill-finish expansion

Groundbreaking for a $750M, 211,000 sq ft Hillsboro expansion adds device fill-finish capacity and targets commercial operations in 2031.

20 August 2026
Genentech expands Hillsboro site with device fill-finish facility

About $750 million to double facility size, add pre-filled syringe and autoinjector capacity, create ~250 manufacturing jobs and begin commercial operations in 2031.

6 November 2025
Heidelberg Materials Reports Q3 Growth, Confirms 2025 Outlook

Q3 results up 5%, operating margin at 25.9%. Transformation Accelerator boosts savings. CCS projects advance, with evoZero cement deliveries starting. 2025 outlook remains positive.

17 October 2025
Heidelberg Materials Launches evoZero, Carbon-Captured Cement in Europe

evoZero, a near-zero carbon cement, is now available in Europe, verified by DNV, supporting sustainable projects like Skøyen Station and DREIHAUS.

Where its projects are

active all projects